Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis
- 1 November 1997
- Vol. 40 (7-8) , 279-282
- https://doi.org/10.1111/j.1439-0507.1997.tb00232.x
Abstract
Fifty strains of Candida isolated from 38 patients with oropharyngeal candidosis were tested in vitro for fluconazole susceptibility with a disk diffusion test and for determination of minimal inhibitory concentrations (MICs). For 25 patients treated with fluconazole, the relationship between in vitro susceptibility and clinical outcome was analysed. A good correlation between in vitro results and therapeutic efficacy was found. In only one case was treatment failure associated with a susceptible strain. Mixed cultures of Candida albicans and non-albicans Candida species were not uncommon and, more interestingly, some samples contained different strains of C. albicans with varied fluconazole susceptibilities. Good agreement was observed between the two techniques used for fluconazole susceptibility testing.Keywords
This publication has 18 references indexed in Scilit:
- FluconazoleDrugs, 1995
- Fluconazole-resistant candidosis in an HIV cohortAIDS, 1994
- Impact of the changing epidemiology of fungal infections in the 1990sEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Fluconazole resistant candida in AIDSJournal of Infection, 1991
- Susceptibility of Candida albicans and Other Yeasts to Fluconazole: Relation Between in Vitro and in Vivo StudiesClinical Infectious Diseases, 1990
- Fluconazole and Other Azoles: Translation of in Vitro Activity to in Vivo and Clinical EfficacyClinical Infectious Diseases, 1990
- In vitro Susceptibility Testing of Candida Isolates from Clinical Specimens to Four Antifungal AgentsChemotherapy, 1990